InvestorsHub Logo

BigBadWolf

08/15/22 12:24 PM

#52743 RE: A2Z #52742

I think exact details would not be known until said agreement was finalized.

Licensing revenues are income generated through the approved usage of one company's products, services, or intellectual property by another entity. Licensing agreements stipulate the terms and conditions under which an entity may use the licensor's materials and the fees that must be paid for its use.

centsability4me

08/15/22 1:31 PM

#52744 RE: A2Z #52742

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=116578000&type=HTML&symbol=TSOI&companyName=Therapeutic+Solutions+International+Inc&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2022-03-25&CK=1419051

Item 1.01 Entry into a Material Definitive Agreement.


On March 24, 2022, Office of Technology Transfer, University of Miami, and Therapeutic Solutions International, Inc. entered into an Asset Transfer and License Agreement. The material information relevant to public disclosure is the following: Within ten (10) days of the Effective Date, 1) TSOI shall make an initial payment of two hundred thousand dollars ($200,000) to UM; 2) Within six (6) months of the Effective Date, TSOI shall make a second payment of one million eight hundred thousand dollars ($1,800,000) (at the completion of the primary endpoint of the phase 2b/3 clinical trial specified in the IND or (ii) one (1) year from the Effective Date), and 3) TSOI shall make a final payment of two million dollars ($2,000,000). In turn TSOI replaces UM as Sponsor, receives all trial doses, and appoints James Veltmeyer, MD, Chief Medical Officer as Principal Investigator.

johnnytrader33

08/16/22 12:08 PM

#52772 RE: A2Z #52742

Yeah went back through the recent trading there aren’t any 500k buys I found for weeks on end. Hopeful for a turnaround but we gotta keep it real